Testing effectiveness (Phase 2)Study completedNCT01090622
What this trial is testing
Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM)
Who this might be right for
Primary ErythromelalgiaInherited Erythromelalgia
Xenon Pharmaceuticals Inc. 4